Vir Biotechnology, Inc.
Biotechnology company · San Francisco, California, United States · Nasdaq: VIR
Vir Biotechnology, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker VIR. It has reported private securities offerings to the US SEC, most recently $32 million sold in a notice filed in 2020.
Vir Biotechnology at a glance
What does Vir Biotechnology do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $32.4 million sold (2020).
Frequently asked questions about Vir Biotechnology
Where is Vir Biotechnology headquartered?
Vir Biotechnology, Inc. is headquartered in San Francisco, California, United States.
What does Vir Biotechnology do?
Vir Biotechnology, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Vir Biotechnology a public company?
Yes. Vir Biotechnology, Inc. trades on Nasdaq under the ticker VIR.
When was Vir Biotechnology founded?
The earliest incorporation on record for Vir Biotechnology, Inc. is in 2016, according to public company registers.
Similar companies
- Cytovale Inc.San Francisco, California, United States
- Ossium Health, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.